184 related articles for article (PubMed ID: 25913621)
1. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.
Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
Tumour Biol; 2015 Sep; 36(10):7515-20. PubMed ID: 25913621
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
Raj SD; Zhou X; Bueso-Ramos CE; Ravi V; Patel S; Benjamin RS; Vadhan-Raj S
Am J Clin Oncol; 2012 Oct; 35(5):462-7. PubMed ID: 21654313
[TBL] [Abstract][Full Text] [Related]
5. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
7. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma.
Nakamura T; Grimer R; Gaston C; Francis M; Charman J; Graunt P; Uchida A; Sudo A; Jeys L
Eur J Cancer; 2013 Jan; 49(2):377-85. PubMed ID: 23058786
[TBL] [Abstract][Full Text] [Related]
8. Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors.
Niimi R; Matsumine A; Iino T; Nakazora S; Nakamura T; Uchida A; Sudo A
BMC Cancer; 2013 Jun; 13():309. PubMed ID: 23799912
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
10. Survival After Distant Metastasis in Head and Neck Cancer.
Wiegand S; Zimmermann A; Wilhelm T; Werner JA
Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
[TBL] [Abstract][Full Text] [Related]
11. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
[TBL] [Abstract][Full Text] [Related]
13. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases.
Li C; Xu Q; Chen L; Luo C; Ying J; Liu J
Bull Cancer; 2017 Mar; 104(3):232-236. PubMed ID: 28063672
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma.
Nakanishi H; Araki N; Kudawara I; Kuratsu S; Matsumine A; Mano M; Naka N; Myoui A; Ueda T; Yoshikawa H
Int J Cancer; 2002 May; 99(2):167-70. PubMed ID: 11979429
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Factors for Predicting Survival in Soft-tissue Sarcoma with Metastatic Disease at Initial Presentation.
Nakamura T; Katagiri H; Shido Y; Hamada S; Yamada K; Nagano A; Yamada S; Tsukushi S; Ishimura D; Matsumine A; Sudo A; Nishida Y
Anticancer Res; 2017 Jun; 37(6):3137-3141. PubMed ID: 28551655
[TBL] [Abstract][Full Text] [Related]
17. Optimal surveillance for postoperative metastasis in breast cancer patients.
Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
[TBL] [Abstract][Full Text] [Related]
18. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study.
Hobusch GM; Bodner F; Walzer S; Marculescu R; Funovics PT; Sulzbacher I; Windhager R; Panotopoulos J
World J Surg Oncol; 2016 Apr; 14():111. PubMed ID: 27091202
[TBL] [Abstract][Full Text] [Related]
20. Is local recurrence in bone and soft tissue sarcomas just a local recurrence or does it impact the overall survival, retrospective cohort from a sarcoma referral center.
Hasan O; Nasir M; Jessar M; Hashimi M; An Q; Miller BJ
J Surg Oncol; 2021 Dec; 124(8):1536-1543. PubMed ID: 34472103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]